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Myotonic dystrophy type 2 (DM2) is a dominantly inherited
disorder caused by a CCTG repeat expansion in intron 1 of
ZNF9 gene.The size and the somatic instability of DM2 expan-
sion complicate the molecular diagnosis of DM2. In situ
hybridization represents a rapid and sensitive method to
obtain a definitive diagnosis in few hours, since it allows the
direct visualization of the mutant mRNA foci on skeletal mus-
cle sections. This approach makes the muscle biopsy an
important tool for definitive diagnosis of DM2.Consequently,a
rapid freezing at ultra cold temperature and a good storage of
muscle specimens are essential to avoid morphologic alter-
ations and nucleic acids degradation.However incorrect freez-
ing or thawing may accidentally occur. In this work we report
that fluorescence in situ hybridization may be applied on
improperly frozen or inappropriately stored muscle biopsies
since foci of mutant mRNA are well preserved and can still be
detected in muscle sections no more useful for histopatholog-
ical evaluation.
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M
yotonic dystrophy type 2 (DM2) is a neu-
romuscular disorder due to the unstable
(CCTG)n repeat expansion in intron 1 of
the zinc finger protein 9 (ZNF9) gene on chromo-
some 3q21.3 (Liquori et al. 2001). Mutant ZNF9
pre-mRNA is spliced and polyadenylated, and the
mRNA is exported to the cytoplasm where normal
levels of ZNF9 protein expression occur (Botta et
al., 2006; Margolis  et al. 2006); however, the
expanded repeats remain in cell nuclei as ribonu-
clear inclusions (Liquori et al. 2001). The DM2
ribonuclear inclusions contain only the CCUG
repeat sequence derived from intron 1 but with no
detectable flanking intronic RNA (Margolis et al.
2006). CCUG-containing mutant mRNAs form
double-stranded hairpin loop structures that bind
specific RNA-binding proteins such as muscle-
blind-like proteins (MBNLs) that colocalize with
ribonuclear inclusions in myonuclei (Mankodi et
al., 2001; Fardaei et al., 2002). Sequestration of
these proteins which are regulators of alternative
splicing, alters the splicing of several pre-mRNA
(reviewed by Osborne and Thornton,2006) such as
the insulin receptor (IR) and the chloride channel
(ClC1) (Savkur et al., 2004; Charlet et al., 2002;
Mankodi et al., 2002). Alterations in IR splicing
leads to insulin insensitivity and predisposition to
diabetes (Savkur et al. 2004) and alterations in
ClC1 splicing results in electrical myotonia
(Charlet  et al., 2002; Mankodi  et al., 2002).
Conventional Southern blot analysis is not ade-
quate for a definitive molecular diagnosis in DM2
due to the extremely large size and somatic insta-
bility of the expansion mutation (Liquori et al.,
2001; Bachinski et al., 2003). The extraordinary
somatic instability complicates the analysis of
genotype-phenotype correlations including those in
the effect of the gender of transmitting parents
and anticipation.The copy number of DM2 CCTG
is below 30 in phenotypically normal individuals
and up 11.000 in patients (Day and Ranum,
2005). A complex genotyping diagnostic proce-
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           dure is now commonly used consisting of a three-
step molecular protocol (Day et al., 2003; Udd et
al., 2003). However, a more practical tool to
obtain a definitive diagnosis in few hours is repre-
sented by in situ hybridization which detects
ribonuclear inclusions in cell nuclei of muscle
fibers (Cardani et al., 2004; Sallinen  et al.,
2004). This approach makes muscle biopsy an
essential tool for DM2 diagnosis. For this reason
muscle specimens should be sent fresh, for rapid
freezing, from the operating room to the patholo-
gy laboratory.To avoid RNA degradation, biopsies
require special precautions with handling of mate-
rial, such as immediate freezing of fresh tissues,
because retrospective genetic analysis is impaired
by conventional tissue processing techniques.
However,many small hospitals are ill-equipped for
snap freezing which requires access to liquid
nitrogen or dry ice; thus, frequently outside hospi-
tals provide specimens that are obscured with
freeze artefacts because they either were submit-
ted incorrectly or were improperly frozen, at the
point of origin prior to shipment. Moreover, an
accidental tissue thawing and refreezing may
occur (for example power failure of the freezer)
causing severe tissue damages and possible RNA
degradation.
Here we report our experience on DM2 muscle
biopsies improperly preserved: these were  no
more useful for a histopathological analysis since
they showed evident morphologic artefacts, but
they proved to be still suitable for diagnosis by flu-
orescence  in situ hybridization (FISH) since
ribonuclear inclusions were preserved and still
detectable on muscle sections.
Materials and Methods 
Incorrectly frozen or accidentally thawed and
refrozen muscle biopsies of biceps brachii or vas-
tus lateralis from genetically confirmed DM2
patients (n=11) have been revaluated by fluores-
cence in situ hybridization (FISH) analysis. Well
preserved muscle biopsies from DM2 or healthy
subjects were used as control (n=5).
The histological diagnosis was performed on
serial sections of muscle biopsies (n=10) which
did not underwent accidental thawing and were
processed for routine histological or histochemi-
cal staining. A standard myofibrillar ATPase
staining protocol was used after preincubation at
pH 4.31, pH 4.61 and pH 9.4 or 10.4 (Dubowitz,
1985). Antibodies against different myosin heavy
chain (MHC) isotypes were used for immunohisto-
chemical identification of fast and slow MHC
fibers according to Vihola et al. (2003).
Quantitative evaluation of fiber diameter was
made with Scion Image (Scion Corporation,
Frederick, MD) as previously reported (Vihola et.
al.,2003).Relative atrophy factor was also calcu-
lated (Dubowitz, 1985).The genetic confirmation
of DM2 was performed by repeat assay described
by Bachinski et al. (2003).
Fluorescence in situ hybridization (FISH) was
performed on 5 µm thick muscle cryosections
using a Texas red labelled (CAGG)5 probe (IDT,
Coralville, IA) as previously reported by Cardani
et al. (2004). Briefly, transverse muscle cryostat
sections were air-dried for 30 min at room tem-
perature and fixed with 2% paraformaldehyde for
30 min at 4°C. After washing in phosphate
buffered saline (PBS). Sections were permeabi-
lized in 2% acetone in PBS (prechilled at -20°C)
for 5 min. After washing in PBS, sections were
incubated in 30% formamide and 2xSSC for l0
min at room temperature and then hybridized with
the probe (1 ng/µL) for 2 h at 37°C in 30% for-
mamide, 2xSSC, 0.02% BSA, 67 ng/µL yeast
tRNA, 2 mM vanadyl ribonucleoside complex.The
sections were washed first in 30% formamide and
2xSSC at 45°C for 30 min,then in lxSSC contain-
ing 165 nM 4,6 diamidino-2-phenylindole (DAPI)
at room temperature for 30 min, and finally
mounted with ProLong (Molecular Probes). The
muscle sections were examined with a Leica DM
RA2fluorescence microscope, under the appropri-
ate conditions of excitation and emission.
Haematoxylin and eosin staining was performed
on serial sections to verify the morphology of the
muscle tissue.
Results
The histopathological analysis performed on
muscle sections obtained from biopsies before the
accidental thawing showed the DM2 characteris-
tic myopathologic alterations (Table 1).Increased
fiber size variation,predominant type 2 fiber atro-
phy and central nucleation, nuclear clumps
expressing almost exclusively fast myosin, were
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(Figure 1A). One muscle biopsy, sent from an out-
side hospital, has been improperly frozen at the
point of origin prior to shipment. Muscle tissue
showed so many freezing artefacts that a histo-
logical or immunohistochemical analysis was not
possible (Figure 1E).
The application of FISH using the fluorescently-
labelled antisense oligonucleotide (CAGG)5 probe
on section of well-frozen muscle biopsies obtained
from genetically confirmed DM2 patients showed
the presence in myonuclei of intense hybridization
signals which represent foci of CCUG-containing
RNA (Figure 1B). In this study, we have per-
formed FISH on muscle sections obtained from
DM2 biopsies with evident morphological alter-
ations due to incorrect freezing or storage. We
have also re-examined old DM2 biopsies, previ-
ously diagnosed by FISH,that underwent acciden-
tal tissue thawing and refreezing.In these biopsies
tissue morphology is completely altered and arte-
facts may be so severe to make the available
material no more useful for further analysis
(Figure 1C). However the application of FISH on
these muscle sections showed that mutant RNA
foci can still be detected in myonuclei (Figure
1D).No aspecific signals are present in these mus-
cle sections both in nuclei or cytoplasm, and the
hybridization results were similar as those
observed in properly-frozen sections.
Frequently, outside hospitals send us muscle
biopsies obtained from suspected DM2 patients to
perform a definitive diagnosis. Sometimes, these
biopsies are either submitted incorrectly or were
incorrectly frozen at the point of origin prior to
shipment; thus, they show evident freezing arte-
facts which make a morphological evaluation of
these muscle tissues impossible (Figure 1E). In
any case, a genetic analysis of these muscle biop-
sies can be carried out. The application of FISH
on genetically confirmed DM2 patients revealed
the presence of ribonuclear inclusions in myonu-
clei of improperly preserved muscle sections,
allowing us to confirm the DM2 diagnosis (Figure
1F).No hybridization signals were present on sim-
ilar muscle sections from patients whose genetic
analysis had not confirmed the DM2 clinical diag-
nosis (Figures 1G, H).
Discussion
Muscle biopsy has an important diagnostic role
in many neuromuscular diseases. Since it is an
invasive investigation, it is important that the
biopsy procedure and subsequent laboratory pro-
cessing of the specimen are well performed to
obtain an optimal sample for diagnosis. Ideally
the specimen should be frozen immediately after
excision, and the correct methods of freezing as
well as the storage of frozen biopsies are crucial
for the histopathological or biomolecular diagno-
sis (Meola, 2005). Indeed, a slow tissue freezing
can yield a riddled sample as a consequence of ice
crystal artefacts formation, while thawing and
refreezing definitely compromise the analysis of
enzymatic activities. Moreover, slow freezing or
thawing-refreezing can results in DNA depletion
and RNA degradation.
Histopathological evaluation of muscle biopsy
appears to be of particular importance for the
definitive diagnosis of DM2 pathology. Indeed,
this pathology has been recently defined as “a dis-
ease of type 2 fibers”since both fiber atrophy and
central nucleation selectively affect type 2 fibers
(Bassez et al., 2008). It appears that variation in
normal fiber size,fiber type differentiation and the
nucleus position can be easily recognized in DM2
muscle sections. Moreover, muscle biopsy repre-
sents an essential tool for a definitive biomolecu-
lar diagnosis of DM2 which may be obtained in
few hours by in situ hybridization which allows a
direct visualization of ribonuclear inclusions on
muscle sections (Cardani et al., 2004; Sallinen et
al., 2004).
Our retrospective study on improperly frozen or
defrozen DM2 biopsies demonstrates that ribonu-
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Table 1. Histopathologic alterations in DM2 muscle.
Patient relative atrophy type 2 fiber nuclear clumps
factor central nucleation
Type 1 fibers Type 2 fibers
BC 0,65 7,04 +
a ++
CI 0,30 8,37 + ++
CS 0,29 3,21 + ++
CC 3,37 6,95 + ++
DD 1,55 0,63 ± ±
LR 0,40 1,12 + +
MG 1,06 8,05 + ++
NG 1,58 5,65 + ++
RO 0,00 1,71 ± ±
Ram 0,58 5,31 + ++
apresence of type 2 fiber central nucleation or nuclear clumps is graded as 0 absent,±
rare, + moderate, ++ numerous; relative atrophy factor n.v. up to 1.110
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Figure 1. (A) Immunohistochemical staining of fast MHC performed on muscle section obtained from a DM2 biopsy before accidental
defrozen (same patient of 1C and 1D). Black arrow indicates nuclear clumps which express the MHC fast isotype. (B)  FISH with the
(CAGG)5 probe on a muscle section obtained from a well frozen DM2 biopsy: ribonuclear inclusions (red spots) are present in the myonu-
clei (blue). C-H. Haematoxylin and eosin staining (C, E, G) and FISH (D, F, H) performed on muscle sections from DM2 biopsies which
underwent accidental tissue thawing and refreezing (C, D) or were incorrectly submitted (E, F), or performed on sections of an incorrect-
ly frozen control biopsy (G, H). In these biopsies, tissue morphology is completely altered; however ribonuclear inclusions are well
detectable in DM2 muscle sections (red spots in D, F) whereas they are not present in the control section (H). clear inclusions, which represent an important
biomarker of this pathology, are well preserved
and still detectable by FISH on muscle sections.
This result indicates that ribonuclear inclusions
are stable and resistant to potential degradation
caused by incorrect method of freezing or by
thawing. Consistently, we have recently demon-
strated by FISH the presence of CUG-containing
RNA foci in the nuclei of gallbladder smooth mus-
cle cells from myotonic dystrophy type 1 (DM1)
patients (Cardani et al., 2008), although  no spe-
cial precautions had been taken to avoid RNA
degradation by RNAse.
Studies carried out on DM1 ribonuclear inclu-
sions suggest that these foci are complex struc-
tures made up of mutant mRNA, RNA-binding
proteins and  transcription factors that physically
interact each other playing an important role in
the maintenance of foci integrity (Dansinthong et
al., 2005; Ebralidze et al., 2004). It seems that
MBNL1 binding to mutant RNA plays an essen-
tial role in ribonuclear inclusions formations and
maintenance in DM1 where this protein also colo-
calizes with CUG-containing RNA nuclear foci
(Dansithong et al., 2005).The stability of mutant
RNA is also demonstrated by their resistance to
the treatments used for formalin fixation and
paraffin embedding.Indeed,Sallinen et al. (2004)
demonstrates that in situ hybridization can be
applied on DM2 paraffin-embedded muscle biopsy
where ribonuclear inclusions are well detectable.
Our results also demonstrate that even in the
presence of a biopsy which had been improperly
frozen, defrozen or incorrectly submitted from
other hospitals, a second biopsy might not be nec-
essary to obtain a definitive DM2 diagnosis. On
this kind of material, retrospective studies can
also be conducted to screen patients with ill-
defined myotonic disorders.
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